SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2023-09-11
👔
AbbVie Inc.
@ABBV_InsiderForm 4 Filing: Alpern Robert J Acquires shares of $ABBV
INSIDER ACQUISITION
⚡ MATERIALITY: 1/10
corporate issuer
AbbVie Inc.
Ticker: $ABBV
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2023-09-07
Shares: 129
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Alpern Robert J, holds the title of Director at AbbVie Inc..
On 2023-09-07, the insider transacted 129 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Alpern Robert J (Director) transacted $0 of $ABBV
Post-Transaction Position: 33,121 shares
SEC Accession No: 0001415889-23-013148 (CIK: 1448074)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.